Literature DB >> 8972741

Susceptibility of DA rats to arthritis induced with adjuvant oil or rat collagen is determined by genes both within and outside the major histocompatibility complex.

J C Lorentzen1, L Klareskog.   

Abstract

Inbred DA rats are remarkably susceptible to arthritis induced both by non-immunogenic mineral oil only (OIA) and by rat collagen II together with mineral oil (rCIA). This fact enables interesting studies concerning which DA genes are associated with the arthritogenicity of adjuvant oil and collagen, respectively. In this paper the authors have investigated the role of genes within and outside the major histocompatibility complex (MHC), in this respect by comparative susceptibility studies in inbred rat strains (DA, LEW) and MHC-congenic strains (DA.1I, DA.1O, DA.1M, DA.1H, LEW.1AV1, PVG.1AV1). The authors confirm earlier reports on the arthritis-promoting nature of the DA MHC haplotype (RT1av1), but demonstrate that neither OIA nor rCIA is restricted to this haplotype or its class II alleles (Ba, Da). A decisive role of non-MHC genes in determining susceptibility is also clear since the PVG.1AV1 strain, with the permissive RT1av1 haplotype, is resistant to both arthritis models. In conclusion, the authors demonstrate that the susceptibility of DA rats to OIA and rCIA is determined similarly, by permissive genes both within and outside the MHC. Second, and more interesting from a general perspective, the investigation demonstrates a notable influence of genes within and outside the MHC on the pathogenic capacity of a non-immunogenic adjuvant oil. This adjuvant is in turn a critical component in provocations leading not only to rCIA but also to many other experimental autoimmune diseases where the influence of 'adjuvant response genes' is rarely considered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972741     DOI: 10.1046/j.1365-3083.1996.d01-354.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  Antigen inhibition of collagen-induced arthritis is associated with up-regulation of IL-4 mRNA and induction of Ox40 on T cells in draining lymph nodes.

Authors:  L Mattsson; K Lundberg; E Mussener; A Jansson; H Erlandsson Harris; P Larsson
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 2.  Rodent models of arthritis: relevance for human disease.

Authors:  R O Williams
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

3.  Identification of rat susceptibility loci for adjuvant-oil-induced arthritis.

Authors:  J C Lorentzen; A Glaser; L Jacobsson; J Galli; H Fakhrai-rad; L Klareskog; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats.

Authors:  B C Carlson; A M Jansson; A Larsson; A Bucht; J C Lorentzen
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

5.  A dominant role for non-MHC gene effects in susceptibility to cyclosporin A (CsA)-induced autoimmunity.

Authors:  J G Damoiseaux; L J Beijleveld; P J van Breda Vriesman
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

6.  Adjuvant oil induces waves of arthritogenic lymph node cells prior to arthritis onset.

Authors:  B C Holm; J C Lorentzen; A Bucht
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

7.  Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats.

Authors:  S Carlsén; A S Hansson; H Olsson; D Heinegård; R Holmdahl
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

Review 8.  Rheumatoid arthritis: identifying and characterising polymorphisms using rat models.

Authors:  Anthony C Y Yau; Rikard Holmdahl
Journal:  Dis Model Mech       Date:  2016-10-01       Impact factor: 5.758

Review 9.  Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs.

Authors:  Nikolai Petrovsky
Journal:  Drug Saf       Date:  2015-11       Impact factor: 5.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.